Suppr超能文献

Editorial: Management of cardiovascular risk factors and other comorbidities in chronic kidney disease.

作者信息

Ali Sehrish, Ajmal Muhammad S, Navaneethan Sankar D

机构信息

Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine.

Section of Nephrology, Michael E. DeBakey Medical Center.

出版信息

Curr Opin Nephrol Hypertens. 2020 Sep;29(5):453-456. doi: 10.1097/MNH.0000000000000633.

Abstract
摘要

相似文献

1
Editorial: Management of cardiovascular risk factors and other comorbidities in chronic kidney disease.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):453-456. doi: 10.1097/MNH.0000000000000633.
2
Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease".
Toxins (Basel). 2020 Jun 11;12(6):384. doi: 10.3390/toxins12060384.
5
Stillbirth is associated with increased risk of long-term maternal renal disease: a nationwide cohort study.
Am J Obstet Gynecol. 2020 Sep;223(3):427.e1-427.e14. doi: 10.1016/j.ajog.2020.02.031. Epub 2020 Feb 26.
6
Increased mortality in chronic kidney disease: a call to action.
Am J Med Sci. 2006 Mar;331(3):150-3. doi: 10.1097/00000441-200603000-00007.
7
Cardiovascular disease in patients with chronic kidney disease.
Herz. 2020 Apr;45(2):122-128. doi: 10.1007/s00059-019-04884-0.

引用本文的文献

1
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.
Biomolecules. 2024 Oct 31;14(11):1393. doi: 10.3390/biom14111393.

本文引用的文献

1
Direct oral anticoagulants in chronic kidney disease: an update.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):489-496. doi: 10.1097/MNH.0000000000000634.
2
Recent advances in the treatment of uremic pruritus.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):465-470. doi: 10.1097/MNH.0000000000000625.
3
Iron deficiency and iron therapy in heart failure and chronic kidney disease.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):508-514. doi: 10.1097/MNH.0000000000000630.
4
Pharmacologic and psychological interventions for depression treatment in patients with kidney disease.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):457-464. doi: 10.1097/MNH.0000000000000629.
5
LDL-cholesterol reduction in chronic kidney disease: options beyond statins.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):480-488. doi: 10.1097/MNH.0000000000000628.
6
Advances in exercise therapy in predialysis chronic kidney disease, hemodialysis, peritoneal dialysis, and kidney transplantation.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):471-479. doi: 10.1097/MNH.0000000000000627.
7
Therapeutic options for chronic kidney disease-associated pulmonary hypertension.
Curr Opin Nephrol Hypertens. 2020 Sep;29(5):497-507. doi: 10.1097/MNH.0000000000000624.
8
Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.
Am J Kidney Dis. 2020 Jun;75(6):935-945. doi: 10.1053/j.ajkd.2019.12.005. Epub 2020 Mar 19.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验